Valent BioSciences announces acquisition of FBSciences

Valent BioSciences LLC, a company that develops and markets low-risk, environmentally compatible technologies and products for agriculture, public health and forestry health, announces the acquisition of FBSciences Holdings, Inc., a company that develops plant, soil and climate of natural origin. With this acquisition, Valent BioSciences and its parent company, Sumitomo Chemical Co. Ltd., now offer a portfolio of integrated biorational solutions, including biostimulants, biopesticides and crop nutrition solutions.

The acquisition of Collierville, Tennessee-based biostimulants FBSciences strengthens Valent BioSciences' share of the growing $3,5 billion global biostimulants market. On October 1, 2022, Valent BioSciences began selling biostimulant products directly to its customer base in the United States. This acquisition will provide a significant growth platform for the two companies' broad range of crop breeding and protection products and forms a key pillar in the overall business strategy.

FBSciences' portfolio of biorational technologies is naturally derived, renewable and sustainable, and forms the basis of a broad offering of solutions for agriculture. The company's core technologies are derived from natural organic matter (NOM), utilizing proprietary production processes that target and extract a diverse blend of unique, biologically active compounds that transform plant, soil and climate health.

The company's flagship biostimulant technology, FBS Transit, forms the basis of its agricultural nutrition and nutrient utilization product lines for use across all crops. It works inside the plant to increase the absorption and translocation of all nutrients, leading to healthier plants that can withstand stress, which results in higher yield and quality.

FBSciences' biopesticides technology, FBS Defense, works inside the plant to increase its ability to defend itself against biotic stresses, including insects and diseases, and increases harvested yields.

Both companies are well recognized for their industry research and development capabilities, which will trigger the commercialization of new technologies and products to provide substantial growth for the biorational arena.

“The acquisition of FBSciences is a natural next step in the evolution of our organization as a global leader in biorationals, including biostimulants,” he said Ted Melnik, president and CEO of Valent BioSciences.

“Our combined organizations have many decades of experience leading our respective markets with science-based technology and innovation. The broad range of biostimulants, biopesticides and crop nutrition products and technologies in the FBSciences portfolio enhances Valent BioSciences' broad family of biorational products, thereby creating an unparalleled range of sustainable, value-added solutions that no other company can offer .”

Sumitomo Chemical has committed to achieving carbon neutrality by 2050, with the aim of reducing the amount of greenhouse gases emitted by its production and commercial activities. “Valent BioSciences’ focus on developing products that sequester atmospheric carbon, combined with FBSciences’ technologies, will help accelerate this effort,” he said. Nobuaki Myth, director and senior executive director of Sumitomo Chemical. “This acquisition will take our strategic Green Transformation initiatives a step further and contribute to the realization of sustainable agriculture and society in the future.”

“The acquisition of FBSciences by Valent BioSciences is a major step forward for the biorational industry,” he said Courtenay Wolfe, CEO and president of FBSciences.

“This tremendous milestone for FBSciences recognizes 16 years of success in developing and commercializing transformative plant, soil and climate health solutions. Our companies share a common science-based approach combined with a mission to improve society and our planet. Adding FBSciences’ expertise, innovative solutions and entrepreneurial spirit to Valent BioSciences’ global powerhouse of resources and robust solutions will provide an unmatched platform in the industry and will continue to drive Valent BioSciences’ leadership position in the rapidly growing biorational space.”